第二原发肺癌再次肺切除术的并发症与生存分析
结果显示无死亡,并发症率36.5%主要为Clavien-Dindo I-II级,中位总生存67个月,5年生存率71.1%。结论认为再次手术并发症不高于首次手术,新发肿瘤多早期诊断,解剖性亚肺叶切除可能是最佳折中。
要点
- 再次肺切除无死亡,并发症率36.5%且多为轻度。
- 中位总生存67个月,5年生存率71.1%。
- 解剖性亚肺叶切除可能是再次手术的最佳选择。
核心结论
- 第二原发非小细胞肺癌再次手术的并发症不高于首次手术。
- 新发肿瘤通常在早期诊断,解剖性亚肺叶切除可能是最佳折中方案。
研究设计与样本
- 回顾性收集2009至2018年间因第二原发非小细胞肺癌接受手术的患者数据。
主要发现
- 两次手术中位间隔25个月(5-44.5个月),患者中位年龄65岁(61-68岁)。
- 肿瘤中位大小16 mm(10-22 mm),75%的病例使用胸腔镜。
- 术式包括全肺切除1例、双肺叶切除1例、肺叶切除15例、肺段切除32例、楔形切除3例。
- 住院时间中位7天(5-9天),死亡率0,并发症率36.5%,主要为Clavien-Dindo I-II级。
- 中位随访28个月(13-50个月),中位总生存67个月(95%CI 60.8-73.1个月),5年生存率和特异性生存率分别为71.1%和67.7%。
临床怎么用
- 对于第二原发非小细胞肺癌,再次手术安全可行,并发症以轻度为主。
- 解剖性亚肺叶切除可作为再次手术的首选术式。
- 首次手术时若存在可疑同时性病灶,可考虑为后续手术保留肺功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Evaluating morbidity and survival of patients operated on for a second primary non-small-cell lung cancer (NSCLC). METHODS: Retrospective collection of data from patients operated on for a second NSCLC between 2009 and 2018. RESULTS: Fifty-two patients met the inclusion criteria. At the time of second pulmonary resection, the median time between the 2 surgeries was 25 months (5-44.5 months). Patients' median age was 65 years (61-68 years). Median tumour size was 16 mm (10-22 mm). Thoracoscopy was used in 75% of cases. The resection was a pneumonectomy (n = 1), bilobectomy (n = 1), lobectomy (n = 15), segmentectomy (n = 32) or wedge resection (n = 3). The length of stay was 7 days (5-9 days). Mortality was null and morbidity was 36.5%, mainly from grade I-II complications according to the Clavien-Dindo classification. The median follow-up was 28 months (13-50 months). The median overall survival was 67 months (95% confidence interval 60.8-73.1 months). Survival at 5 years and specific survival were 71.1% and 67.7%, respectively. CONCLUSIONS: A second surgical resection of either synchronous or metachronous NSCLC has a morbidity that is not superior to the morbidity of the first operation. The new tumour is usually diagnosed at an early stage. An anatomical sublobar resection is most likely the best compromise. It might also be considered for the first operation when there is a suspicious synchronous lesion that may require surgery at a later stage.
引用
- Abid W, Seguin-Givelet A, Brian E, et al. Second pulmonary resection for a second primary lung cancer: analysis of morbidity and survival. Eur J Cardiothorac Surg. 2021. PMID: 33367556. doi:10.1093/ejcts/ezaa438
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。